全文获取类型
收费全文 | 8349篇 |
免费 | 441篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 62篇 |
儿科学 | 205篇 |
妇产科学 | 116篇 |
基础医学 | 1067篇 |
口腔科学 | 197篇 |
临床医学 | 497篇 |
内科学 | 2457篇 |
皮肤病学 | 74篇 |
神经病学 | 564篇 |
特种医学 | 374篇 |
外科学 | 1335篇 |
综合类 | 20篇 |
预防医学 | 213篇 |
眼科学 | 123篇 |
药学 | 607篇 |
中国医学 | 9篇 |
肿瘤学 | 926篇 |
出版年
2023年 | 57篇 |
2022年 | 108篇 |
2021年 | 211篇 |
2020年 | 126篇 |
2019年 | 160篇 |
2018年 | 195篇 |
2017年 | 175篇 |
2016年 | 175篇 |
2015年 | 224篇 |
2014年 | 251篇 |
2013年 | 329篇 |
2012年 | 503篇 |
2011年 | 595篇 |
2010年 | 351篇 |
2009年 | 304篇 |
2008年 | 518篇 |
2007年 | 563篇 |
2006年 | 560篇 |
2005年 | 519篇 |
2004年 | 541篇 |
2003年 | 544篇 |
2002年 | 500篇 |
2001年 | 125篇 |
2000年 | 98篇 |
1999年 | 118篇 |
1998年 | 102篇 |
1997年 | 95篇 |
1996年 | 61篇 |
1995年 | 61篇 |
1994年 | 47篇 |
1993年 | 60篇 |
1992年 | 56篇 |
1991年 | 50篇 |
1990年 | 56篇 |
1989年 | 46篇 |
1988年 | 41篇 |
1987年 | 33篇 |
1986年 | 30篇 |
1985年 | 38篇 |
1984年 | 25篇 |
1983年 | 24篇 |
1982年 | 20篇 |
1981年 | 13篇 |
1980年 | 18篇 |
1979年 | 13篇 |
1978年 | 19篇 |
1977年 | 9篇 |
1970年 | 7篇 |
1969年 | 10篇 |
1967年 | 7篇 |
排序方式: 共有8846条查询结果,搜索用时 109 毫秒
991.
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia 总被引:23,自引:7,他引:23
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
992.
Atsushi?TanakaEmail author Xiong?Ma Osamu?Yokosuka Martin?Weltman Hong?You Deepak?N.?Amarapurkar Yoon?Jun?Kim Zaigham?Abbas Diana?A.?Payawal Ming-Ling?Chang Cumali?Efe Ersan?Ozaslan Masanori?Abe Robert?Mitchell-Thain Mikio?Zeniya Kwang?Hyub?Han John?M.?Vierling Hajime?Takikawa 《Hepatology International》2016,10(6):909-915
During the 25th annual meeting of the Asia–Pacific Association for the Study of the Liver (APASL 2016) in Tokyo, we organized and moderated an inaugural satellite symposium on the autoimmune liver diseases, autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). Following the keynote lecture by John M. Vierling (USA), speakers from the Asia–Pacific region provided an up-to-date perspective on the epidemiology, clinical practice and research in AIH and PBC in the Asia–Pacific region. Although epidemiology and clinical features of AIH seem to be similar in East Asia compared to those in western countries, the majority of patients with AIH are detected at an advanced stage and have higher mortality rates in South Asia, indicating an unmet need for earlier diagnosis and the initiation of appropriate immunosuppressive treatment. PBC is more commonly seen in Australia and East Asia. As of 2016, clinical practice guidelines (CPG) for PBC have been published in Japan and China. Ursodeoxycholic acid (UDCA) is recommended as a first-line therapy by both CPG. Nevertheless, one of the unmet therapeutic needs in PBC is the treatment of patients refractory to or intolerant of UDCA. It is of interest that the prevalence of chronic hepatitis B (CHB) in PBC patients was low in Taiwan and mainland China where the prevalence of CHB is very high. In this review, we overview this exciting and epoch-making symposium. 相似文献
993.
Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats 总被引:1,自引:0,他引:1
Mikami K Goto T Miura K Ohshima S Yoneyama K Lin JG Watanabe D Segawa D Kataoka E Shibuya T Watanabe S 《Journal of gastroenterology》2005,40(3):260-265
Background Gabexate mesilate, a synthetic protease inhibitor, is used to treat acute pancreatitis and disseminated intravascular coagulation because it inhibits various serine proteases; however, whether gabexate mesilate prevents acute liver failure has not yet been studied. The aim of the present study was to investigate the effect of gabexate mesilate in carbon tetrachloride (CCl4)-induced liver injury in rats.Methods Acute hepatic failure was induced by administration of CCl4 intragastrically to male Sprague–Dawley rats. The effects of gabexate mesilate were examined in terms of serum transaminase levels, liver histology, and the prognosis of rats.Results Gabexate mesilate treatment significantly decreased the elevation of serum transaminase levels and improved liver histology 24h after the administration of CCl4 (0.2ml/100g rat weight). Plasma tumor necrosis factor- (TNF-) and interleukin-1 (IL-1) decreased significantly in the gabexate mesilate-treated rats compared with saline-treated rats. Gabexate mesilate treatment also significantly improved survival rate after a lethal dose of CCl4 (0.5ml/100g rat weight) from 0% to 20%.Conclusions Gabexate mesilate treatment attenuated CCl4-induced liver injury via a suppression of proinflammatory cytokine production. In addition, these investigations suggest that gabexate mesilate treatment may provide therapeutic strategies for human acute liver failure. 相似文献
994.
995.
996.
997.
Tsukasaki K Tobinai K Shimoyama M Kozuru M Uike N Yamada Y Tomonaga M Araki K Kasai M Takatsuki K Tara M Mikuni C Hotta T;Lymphoma Study Group of the Japan Clinical Oncology Group 《International journal of hematology》2003,77(2):164-170
Aggressive adult T-cell leukemia-lymphoma (ATL) generally has a very poor prognosis. Deoxycoformycin (DCF, pentostatin), an inhibitor of adenosine deaminase, has shown promising therapeutic efficacy for ATL. To develop a new effective therapy against aggressive ATL, we carried out a multicenter phase II study of DCF-containing combination chemotherapy. Sixty-two previously untreated patients with ATL (34, 21, and 7 patients with diseases of the acute, lymphoma, and unfavorable chronic types, respectively) were enrolled, but 2 were ineligible because they were judged to be favorable chronic types. A regimen of 1 mg/m2 vincristine intravenously on days 1 and 8, 40 mg/m2 doxorubicin intravenously on day 1, 100 mg/m2 etoposide intravenously on days 1 through 3, 40 mg/m2 prednisolone orally on days 1 and 2, and 5 mg/m2 DCF intravenously on days 8, 15, and 22 was administered every 28 days for 10 cycles unless disease progression or toxic complications occurred. Fifty-two percent of 60 eligible patients responded (95% confidence interval [CI], 38%-65%), with 17 patients (28%) achieving a complete response (CR) (95% CI, 17%-41%) and 14 achieving a partial response. The CR rate was inferior to those of both the previous Japan Clinical Oncology Group (JCOG) study (JCOG8701, 43%), a 9-drug combination chemotherapy of the second generation, and the subsequent JCOG9303 study (35%), a granulocyte colony-stimulating factor-supported, dose-intensified, 9-drug regimen. The median survival time of the 60 eligible patients in JCOG9109 was 7.4 months, and the estimated 2-year survival rate was 15.5%; these results were identical with those of JCOG8701 but inferior to those of JCOG9303. Grade 4 neutropenia and infection of grade 3 or greater were frequent (67% and 22%, respectively), and treatment-related death was observed in 4 patients (7%), septicemia in 2, and cytomegalovirus pneumonia in 2. We conclude that DCF-containing combination chemotherapy is not a promising regimen against aggressive ATL. 相似文献
998.
Resection of an icteric type hepatoma with tumor thrombi filling the right posterior bile duct 总被引:3,自引:0,他引:3
Nishio H Miyata K Hanai M Kato M Yoneyama F Kobayashi Y 《Hepato-gastroenterology》2002,49(48):1682-1685
A 67-year-old male with jaundice was found to have hepatocellular carcinoma in the right hepatic lobe and tumor thrombi in the common hepatic duct. Physicians initially considered the tumor unresectable, and treated the patient with transcatheter arterial infusion chemotherapy and biliary endoprosthesis. The patient developed a liver abscess after the second transcatheter arterial infusion, and the physicians consulted our department for another form of therapy. Percutaneous transhepatic biliary drainage was performed to relieve revived obstructive jaundice. Cholangiography revealed tumor thrombi extending through the right posterior segmental bile duct into the common hepatic duct. Most biliary branches of the caudate lobe joined with the left lateral posterior segmental branch. Arterial and portal venous branches of the caudate lobe were not involved. Right hepatic lobectomy and extrahepatic bile duct resection were performed 1 year after initial diagnosis. On histologic examination, the epithelium of the right posterior segmental bile duct, which was filled with the tumor thrombi, was not detected. The patient is alive without recurrence 24 months after surgery. Careful investigation of biliary branches of the caudate lobe on cholangiography is essential to determine the necessity of caudate lobectomy in patients with hepatocellular carcinoma and tumor thrombi filling the right posterior segmental bile duct. 相似文献
999.
Tracking stem cells in the cardiovascular system 总被引:2,自引:0,他引:2
Stem cells are a promising approach to cardiovascular therapeutics. Animal experiments have assessed the fate of injected stem cells through ex vivo methods on sacrificed animals. Approaches are needed for in vivo tracking of stem cells. Various imaging techniques and contrast agents for stem cell tracking will be reviewed. 相似文献
1000.
Toshiaki Asano Masanori Kitaichi Tetunari Hase Harunori Nakashima Takashi Abe Morihide Ando Joe Shindo Michiaki Horiba 《Nihon Kokyūki Gakkai zasshi》2006,44(3):173-177
A 52-year-old woman presented with low grade fever and fatigue. She had diffuse micronodules in both lung fields on chest X-ray. Chest CT showed diffuse multiple small nodules. Laboratory examination revealed high values for C-reactive protein, together with anemia and polyclonal hyper-immunoglobulinemia and an elevated interleukin-6 level. Although we suspected multicentric Castleman's disease, thoracoscopic lung biopsy revealed primary pulmonary MALT lymphoma by immunohistochemical analysis of tissue specimens. After COP and rituximab therapy, partial remission was obtained. 相似文献